Cyclin D1 integrates G9a-mediated histone methylation.


Journal

Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562

Informations de publication

Date de publication:
05 2019
Historique:
received: 06 03 2018
accepted: 08 01 2019
revised: 03 12 2018
pubmed: 6 2 2019
medline: 12 10 2019
entrez: 6 2 2019
Statut: ppublish

Résumé

Lysine methylation of histones and non-histone substrates by the SET domain containing protein lysine methyltransferase (KMT) G9a/EHMT2 governs transcription contributing to apoptosis, aberrant cell growth, and pluripotency. The positioning of chromosomes within the nuclear three-dimensional space involves interactions between nuclear lamina (NL) and the lamina-associated domains (LAD). Contact of individual LADs with the NL are dependent upon H3K9me2 introduced by G9a. The mechanisms governing the recruitment of G9a to distinct subcellular sites, into chromatin or to LAD, is not known. The cyclin D1 gene product encodes the regulatory subunit of the holoenzyme that phosphorylates pRB and NRF1 thereby governing cell-cycle progression and mitochondrial metabolism. Herein, we show that cyclin D1 enhanced H3K9 dimethylation though direct association with G9a. Endogenous cyclin D1 was required for the recruitment of G9a to target genes in chromatin, for G9a-induced H3K9me2 of histones, and for NL-LAD interaction. The finding that cyclin D1 is required for recruitment of G9a to target genes in chromatin and for H3K9 dimethylation, identifies a novel mechanism coordinating protein methylation.

Identifiants

pubmed: 30718920
doi: 10.1038/s41388-019-0723-8
pii: 10.1038/s41388-019-0723-8
pmc: PMC6542714
mid: NIHMS1518294
doi:

Substances chimiques

CCND1 protein, human 0
Chromatin 0
Histocompatibility Antigens 0
Histones 0
Cyclin D1 136601-57-5
EHMT2 protein, human EC 2.1.1.43
Histone-Lysine N-Methyltransferase EC 2.1.1.43

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4232-4249

Subventions

Organisme : NCI NIH HHS
ID : R01 CA086072
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA075503
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA070896
Pays : United States

Références

Mol Cell Biol. 2006 Jun;26(11):4240-56
pubmed: 16705174
Nucleic Acids Res. 2010 Sep;38(17):e169
pubmed: 20660011
Clin Transl Sci. 2008 Sep;1(2):107-15
pubmed: 20443831
Am J Pathol. 2013 Jul;183(1):3-9
pubmed: 23790801
Mol Cell. 2004 Jun 18;14(6):727-38
pubmed: 15200951
Cell. 2012 Jun 22;149(7):1474-87
pubmed: 22726435
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
J Biol Chem. 2005 Apr 29;280(17):16934-41
pubmed: 15713663
J Exp Med. 2012 Apr 9;209(4):661-9
pubmed: 22412156
Cancer Res. 2014 Jan 15;74(2):508-19
pubmed: 24282282
Cancer Res. 2006 Aug 1;66(15):7562-70
pubmed: 16885355
Cell. 2012 Aug 31;150(5):934-47
pubmed: 22939621
Cold Spring Harb Symp Quant Biol. 2010;75:517-24
pubmed: 21209388
Mol Cell. 2010 Jul 9;39(1):71-85
pubmed: 20603076
Neoplasia. 2011 Aug;13(8):676-84
pubmed: 21847359
J Biol Chem. 2005 Feb 18;280(7):5563-70
pubmed: 15590646
Mol Cell. 2007 Aug 17;27(4):596-608
pubmed: 17707231
Cell. 2012 Jul 6;150(1):12-27
pubmed: 22770212
Mol Cell Biol. 2004 Sep;24(17):7598-611
pubmed: 15314168
Nat Cell Biol. 2010 Jul;12(7):719-27
pubmed: 20562864
J Biol Chem. 2005 Aug 19;280(33):29728-42
pubmed: 15951563
Mol Cell. 2014 Jan 23;53(2):277-89
pubmed: 24389103
Oncotarget. 2015 Apr 20;6(11):8525-38
pubmed: 25940700
Genet Mol Biol. 2018 Apr./Jun;41(2):488-495
pubmed: 30088609
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Oncogene. 2007 Jan 4;26(1):77-90
pubmed: 16799634
Genes Dev. 2006 Nov 15;20(22):3089-103
pubmed: 17085482
Cancer Cell. 2010 Oct 19;18(4):329-40
pubmed: 20951943
Mol Cell. 2012 Jan 13;45(1):123-31
pubmed: 22178396
Nucleic Acids Res. 2010 Jun;38(11):3503-11
pubmed: 20159995
J Cell Mol Med. 2009 Jun;13(6):1059-85
pubmed: 19210577
J Cell Biol. 2003 Mar 3;160(5):685-97
pubmed: 12604593
Cell. 1993 May 7;73(3):487-97
pubmed: 8343202
J Biol Chem. 2010 Mar 26;285(13):9636-41
pubmed: 20118233
Cell. 2006 Sep 8;126(5):995-1004
pubmed: 16959577
Cell. 2013 Mar 28;153(1):178-92
pubmed: 23523135
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D284-8
pubmed: 15608197
Genes Dev. 2011 Apr 15;25(8):781-8
pubmed: 21498567
Stem Cells. 2014 Jun;32(6):1602-15
pubmed: 24302516
Nature. 1994 Jun 23;369(6482):669-71
pubmed: 8208295
Nucleic Acids Res. 2016 Sep 6;44(15):7173-88
pubmed: 27141965
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11632-7
pubmed: 21709239
Genome Res. 2010 Oct;20(10):1352-60
pubmed: 20736230
Cell Metab. 2013 Dec 3;18(6):896-907
pubmed: 24315373
Mol Cell. 2007 Feb 9;25(3):473-81
pubmed: 17289593
Genes Dev. 1998 Nov 15;12(22):3488-98
pubmed: 9832502
Nature. 2000 Aug 10;406(6796):593-9
pubmed: 10949293
Nucleus. 2010 May-Jun;1(3):284-97
pubmed: 21327076
Nat Chem Biol. 2008 Jun;4(6):344-6
pubmed: 18438403
Cancer Res. 2010 Nov 1;70(21):8802-11
pubmed: 20940395
Mol Biol Cell. 2008 Jun;19(6):2566-78
pubmed: 18367547
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11257-62
pubmed: 15269344
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11567-72
pubmed: 16864783
Mol Cell Biol. 2006 Jul;26(14):5449-69
pubmed: 16809779
Mol Cell. 2010 May 28;38(4):603-13
pubmed: 20513434
J Neuropathol Exp Neurol. 1996 Sep;55(9):1009-20
pubmed: 8800097
Science. 2002 May 10;296(5570):1132-6
pubmed: 12004135
Cancer Sci. 2011 Jul;102(7):1298-305
pubmed: 21539681
Neurogenesis (Austin). 2017 May 2;4(1):e1316888
pubmed: 28596979
Genes Dev. 2005 Apr 1;19(7):815-26
pubmed: 15774718
Mol Endocrinol. 2013 Sep;27(9):1415-28
pubmed: 23864650
Cell. 2015 Sep 24;163(1):134-47
pubmed: 26365489
J Clin Invest. 2012 Mar;122(3):833-43
pubmed: 22307325
Curr Cancer Drug Targets. 2017;17(6):555-568
pubmed: 27174055
Immunity. 2018 Jan 16;48(1):75-90.e6
pubmed: 29343442
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cell Death Dis. 2017 Apr 6;8(4):e2726
pubmed: 28383547
Genome Res. 2003 Sep;13(9):2129-41
pubmed: 12952881
EMBO Rep. 2015 May;16(5):610-7
pubmed: 25784758
Mol Cell Biol. 2003 Sep;23(17):6159-73
pubmed: 12917338
Mol Endocrinol. 2001 May;15(5):797-811
pubmed: 11328859

Auteurs

Zhiping Li (Z)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Xuanmao Jiao (X)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Gabriele Di Sante (G)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Adam Ertel (A)

Department of Cancer Biology, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA, 19107, USA.

Mathew C Casimiro (MC)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Min Wang (M)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Sanjay Katiyar (S)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA.

Xiaoming Ju (X)

Department of Cancer Biology, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA, 19107, USA.

D V Klopfenstein (DV)

Center for Integrated Bioinformatics, School of Biomedical Engineering, Drexel University, Philadelphia, PA, 19104, USA.

Aydin Tozeren (A)

Center for Integrated Bioinformatics, School of Biomedical Engineering, Drexel University, Philadelphia, PA, 19104, USA.

William Dampier (W)

Department of Microbiology & Immunology, Drexel University College of Medicine, Philadelphia, PA, 19104, USA.

Iouri Chepelev (I)

Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.

Albert Jeltsch (A)

Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, D-70569, Stuttgart, Germany.

Richard G Pestell (RG)

Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA, 18902, USA. richard.pestell@bblumberg.org.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 637551, Singapore. richard.pestell@bblumberg.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH